Dear MS,

[anonymous]

Monkeys could have launched Ocrevus.

Dead monkeys. And keep jerking off to best launch and 15 competitors. Competitors have comparable efficacy and safety. Ocrevus sold itself as the best agent on the market. Let’s see how the cream of the crop (don’t make me piss myself) of crap agents handles their first true competitor.

 

[anonymous]

I was on the RA and Ocre teams. So don't make me laugh...

It’s so obvious to those of us outsiders, that you guys posting negative responses about Ocrevus success, are legacies that worked in Oncology, and had to work a couple days a year. Anyway, attend a lunch with 7 other Genentech Onc Reps. Since you worked in RA let me guess, you are no longer here, or not that successful? Like a lawyer I already know the answer to that question. Until you’ve actually competed in the MS Market you really have no idea what you are talking about. Again, a simple thank you will suffice.

 

[anonymous]

It’s so obvious to those of us outsiders, that you guys posting negative responses about Ocrevus success, are legacies that worked in Oncology, and had to work a couple days a year. Anyway, attend a lunch with 7 other Genentech Onc Reps. Since you worked in RA let me guess, you are no longer here, or not that successful? Like a lawyer I already know the answer to that question. Until you’ve actually competed in the MS Market you really have no idea what you are talking about. Again, a simple thank you will suffice.

I agree with the other posters. I came from the MS market to join the ocre team. Trust me, Ocre sells itself! Our Micky Mouse message was not the reason why. Any warm body could take credit for the money it raked in. Don't be so self important! Not sure what color of kool aid you have been drinking. Most, if not, all successful people in every BU already left Genentech. Like a lawyer? You are so full of it.

 

[anonymous]

It’s so obvious to those of us outsiders, that you guys posting negative responses about Ocrevus success, are legacies that worked in Oncology, and had to work a couple days a year. Anyway, attend a lunch with 7 other Genentech Onc Reps. Since you worked in RA let me guess, you are no longer here, or not that successful? Like a lawyer I already know the answer to that question. Until you’ve actually competed in the MS Market you really have no idea what you are talking about. Again, a simple thank you will suffice.

LMFAO. Like a lawyer... you’re a drug rep and most of this brand is seen to be low talent. Cuts start 2021 starting with CRMs and Lawyer-like reps. You’re welcome.

 

[anonymous]

Hard to argue with the most successful launch on pharmaceutical history. Even if O is a no-brainer, you can't take away the results.

 

[anonymous]

It’s so obvious to those of us outsiders, that you guys posting negative responses about Ocrevus success, are legacies that worked in Oncology, and had to work a couple days a year. Anyway, attend a lunch with 7 other Genentech Onc Reps. Since you worked in RA let me guess, you are no longer here, or not that successful? Like a lawyer I already know the answer to that question. Until you’ve actually competed in the MS Market you really have no idea what you are talking about. Again, a simple thank you will suffice.

OMG! Think like a lawyer? I cannot stop laughing. Not that lawyers are known for their intellect or integrity... Be real, you are an overpaid drug rep. The fact that you are stuck on this titanic, you are not that marketable. Those who chose to get out because we could.

 

[anonymous]

OMG! Think like a lawyer? I cannot stop laughing. Not that lawyers are known for their intellect or integrity... Be real, you are an overpaid drug rep. The fact that you are stuck on this titanic, you are not that marketable. Those who chose to get out because we could.

Make your retort cogent, next time, prick.

 

[anonymous]

There are a lot of good people at Genentech. Not everyone that “left” (got fired) were that great. Of course they all are on here talking smack. I’m in Onc, but the people I have met on the MS side are quality people, and are keeping us a float for the next couple of years. And it was the most successful launch in industry history, though not the best drug. If you don’t work here any longer please go away. Those of us still here will succeed.

 

[anonymous]

There are a lot of good people at Genentech. Not everyone that “left” (got fired) were that great. Of course they all are on here talking smack. I’m in Onc, but the people I have met on the MS side are quality people, and are keeping us a float for the next couple of years. And it was the most successful launch in industry history, though not the best drug. If you don’t work here any longer please go away. Those of us still here will succeed.

I’ll never go away. Watching the AH Minnow slowly sink and take with it the fodder of leadership that helped destroy what was once a premier biotech is worth watching from afar. MS is probably the only valid franchise there. The best left on their own (no, Ian and Troy The Boy Cocks, you don’t count as the best) to seek a future beyond the SSF political party. Those there are generally those who got lucky to keep their job, kiss up to worthless leaders and who have no drive to look outside for something better so you wring your hands and say to yourself every night when you go to bed, “this will be OK, I’m in a good place”. Only time will tell.

 

[anonymous]

I agree with the other posters. I came from the MS market to join the ocre team. Trust me, Ocre sells itself! Our Micky Mouse message was not the reason why. Any warm body could take credit for the money it raked in. Don't be so self important! Not sure what color of kool aid you have been drinking. Most, if not, all successful people in every BU already left Genentech. Like a lawyer? You are so full of it.

I had the great pleasure of being a part of that launch team. To be honest both are correct here. We recruited the cream of the crop, and leveraged their relationships to build the success of OCRE.

AND, there were territories when the first leaves(Sabbaticals, Mat leaves, etc), that continued to perform at 'excellence' level. Not saying all territories saw this, and MS is a hard market.

Honestly what was the secret sauce? If I had to guess, the first approved therapy to show efficacy in Progressive MS, combined with strong efficacy and lower AE's then Alemtuzumab/Natalizumab.

Which ultimately means, that's a positive that OCRE did not become the full successor to RTX in Immunology. The 'failure' turned into the bell of the ball.

I can tell you the product did well in spite of the home offices best efforts. The heart were in the right place, and many of the struggles we faced were similar things that held back other products.(like Xolair, or other infused immunology treatments). It's really hard to get customers to adopt a pain in the ass acquisition and infusion process when they won't loose their license for not using a GNE product.

Will it be the cash cow for the next 20 years? No. Look at the patent and LOE dates...